NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Lupin Pharmaceuticals (LPI), US subsidiary of Indian drug maker Lupin, has received the US Food and Drug Administration's (FDA) approval for its Armodafinil tablets indicated to improve wakefulness in adult patients with obstructive sleep apnea, narcolepsy or shift work disorder. Armodafinil is a generic version of Cephalon Inc's Nuvigil tablets.…

news

Kempharm receives clearance from FDA to initiate clinical program for KP201/IR, a single-entity benzhydrocodone HCL immediate release abuse-deterrent prodrug for the treatment of acute pain. Kempharm expects to conduct human clinical trials of KP201/IR in 2017. Intend to initiate human clinical trials of KP201/IR in first half of 2017. Remain…

news

Aegerion Pharmaceuticals, Inc. and QLT Inc. announced the completion of their merger transaction, as a result of which Aegerion is now an indirect wholly-owned subsidiary of QLT. In conjunction with the closing of the merger, QLT changed its name to Novelion Therapeutics Inc. (“Novelion”). Novelion’s common shares will begin trading…

news

U.S. biotech company Momenta Pharmaceuticals Inc said on Tuesday its experimental biosimilar version of AbbVie Inc's top-selling autoimmune drug, Humira, met the main goal in a late-stage trial involving patients with a form of psoriasis. As it is not possible to produce exact copies of biotech drugs made from living…

news

Phaserx receives orphan drug designation from FDA for PRX-OTC for the treatment of ornithine transcarbamylase deficiency. PRX-OTC, which is being developed for treatment of ornithine transcarbamylase deficiency has received orphan drug designation by U.S. FDA.   Source : reuters.com

news

Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler. The companies said in a statement on Monday that this is the first time the medical cannabis sector has complied with pharmaceutical standards for inhalation,…

news

Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels. Financial details of the…

news

Intellipharmaceutics submits new drug application for Rexista (oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain. Intellipharmaceutics International - Has identified potential manufacturing partners; currently evaluating manufacturing options for Rexista in U.S.   Source : reuters.com

news

Hikma Pharmaceuticals PLC (Hikma) , the fast growing multinational pharmaceutical group, announces that its wholly owned US affiliate, West-Ward Pharmaceuticals Corp. (West-Ward), has signed a development and licensing agreement with Vectura for its generic salmeterol product (VR730). Generic salmeterol is a generic long acting beta-agonists (LABA) for the treatment of…

news

Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva. Aurobindo Pharma Ltd says Arrow Generiques will integrate the products with existing commercial operations in France. Aurobindo Pharma Ltd says Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the…